NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in every cell of your body. It plays a direct role in energy production, DNA repair, and the activation of proteins that regulate cellular aging. The human bodies NAD+ levels drop significantly as you get older. Most people lose up to 50% of their NAD+ between ages 40 and 60, which contributes to fatigue, slower recovery, cognitive decline and accelerated aging.
Already have an account? Log in
SEQUORA NAD+ 500mg is a coenzyme (nicotinamide adenine dinucleotide) that’s found naturally in every cell of your body, its part of your energy production, DNA repair and proteins that regulate your cellular aging. As you get older your NAD+ levels drop by a large amount, males lose between 50% of their NAD+ between the ages of 40 and 60. SEQUORA NAD+ Helps combat this by reducing fatigue, aiding rcovery and improving cognitive ability.
The 500mg figure indicates the total stated content across all three compounds, not the concentration or amount delivered per withdrawal. Review the specifications for your selected format.
All of our products are third party laboratory tested to ensure both purity and verification of the peptide itself.
Standard doses of NAD+ are from 50-200mg per injection, it depends on the phase you’re in. It’s best to start with what is called a loading phase. As with most peptides it’s always good to start with the lowest recommended dose and slowly increase to find the best possible effects while keeping the dose low enough to not be impacted by heavy side effects.
SEQUORA recommends daily injections during your loading phase and injections 2-3 times weekly during maintenance.
Yes and no, during loading phases your injection amounts and frequency if following our guidance, will remain the same. However during maintenance the amount of NAD+ you are injecting per administration will change depending on your goals with taking NAD+
If it’s for regular anti-aging and cellular repair, a 50-100mg injection 2-3 times per week is a good point of reference.
If you’re looking to improve energy and cognitive performance a slightly higher maintenance dose of 100-150mg 3 times per week is advisable.
For Athletic Recovery although NAD+ is extremely beneficial you would look at stacking it with something like the Wolverine Stack and injecting NAD+ 150-200mg 2-3 times per week.
Some SEQUORA clients have reported improved energy and mental clarity within the first few days of a loading phase. More substantial changes in sleep quality, recovery, and overall vitality typically develop over weeks 2 through 4. Body composition and anti-aging benefits build gradually over 2-3 months of consistent use.
NAD+ can be delivered via IV or IM injections, however the SEQUORA NAD+ Pens are created with subcutaneous injections in mind. If you purchase a vial you can self administer although SEQUORA do not support guidance and dosage for these methods.
Product information, handling and safety
What Temperature should I store my NAD+ at?
What are the best practices for using NAD+ safely?
The documentation behind NAD+ and it's uses
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in every cell of your body. It plays a direct role in energy production, DNA repair, and the activation of proteins that regulate cellular aging. The human bodies NAD+ levels drop significantly as you get older. Most people lose up to 50% of their NAD+ between ages 40 and 60, which contributes to fatigue, slower recovery, cognitive decline and accelerated aging.
Upon delivery store in a refridgerator between 2-8°C.
Avoid dropping or heavy-handling of your NAD+.
Please do not freeze your SEQUORA NAD+ Pen as this can compromise the peptide.
Your product has been shipped in secure packaging to prevent any potential issues however if you believe your NAD+ has been compromised contact us directly.
Your SEQUORA NAD+ Pen will last 12 months from the date of manufacture providing you follow the storage instructions provided.
SEQUORA NAD+ Vials before reconstitution can last up to 4 years at -5°C
NAD+ can be kept at room temperature however it’s shelf life when held at this temperature reduces to 14-28 days.
Before handling your NAD+, needles or injection material, ensure your research area is clean and clear.
Wash your hands with warm water and soap and allow to dry fully before handling any SEQUORA products to prevent cross contamination or infection risks.
If at any point the cleanliness of your injection or environment is compromised, restart this step.
Never re-use or share needles/syringes. Ensure your needle tips or syringe is sealed and new before injection.
Before using your SEQUORA NAD+ Pen, using an alcohol swab, wipe the tip of the cartridge after removing the lid to the pen.
If at any point you touch something unhygienic or potentially dirty, re-wash your hands and use new equipment.
Ensure that your needle tips, syringes and vials are safely disposed of post-use.
This could mean a sharps bin or safe container. Most needle tips and syringes have removable tops that can be replaced onto the used needle.
Try to keep your injection site clean for atleast 30 minutes post-injection to prevent infection risks.
NAD+ injections and can cause potential side effects. Human safety evidence is limited and effects may differ between individuals. Reliable side-effect frequencies and long-term risks have not been established.
Reported symptoms
These symptoms are described in clinical-use reports and informal accounts.
Injection-site complications
Increasing pain, spreading redness, warmth, swelling, discharge or fever may indicate infection or another significant reaction.
When to seek medical help
Seek prompt medical assessment for severe chills, shaking, repeated vomiting, fever, persistent dizziness or worsening injection-site symptoms. Tell the clinician what was administered, by which route and when symptoms began.
Call 999 immediately for chest pain, significant breathing difficulty, collapse or sudden swelling of the lips, tongue or throat.
Some minor symptoms may respond to supportive measures. New or worsening symptoms require assessment rather than simply continuing administration.
Nausea or stomach discomfort
Flushing, headache or dizziness
Fatigue
Injection-site soreness or bruising
Severe reactions
Stop administration and seek urgent medical assessment for severe chills, shaking, repeated vomiting or fever. Do not reuse a suspected vial or attempt another administration to test whether the reaction happens again.
Call 999 immediately for chest pain, significant breathing difficulty, collapse or a severe allergic reaction.
NAD+ is split into two phases, the Loading Phase & Maintenance phase. The below dosage chart breaks down the pen setting, dose amount and how much liquid will actually be injected.
| DOSE | PHASE | SCHEDULE | PEN DIAL SETTING | LIQUID VOLUME |
|---|---|---|---|---|
| 100 mg | Days 1–14 | Once daily | 60 | 0.60 ml |
| 100 mg | Week 3 onwards | Every 2–3 days | 60 | 0.60 ml |
Understanding the figures
The 500 mg figure represents the total stated NAD+ content in the entire pen, not an individual dose. At a final volume of 3 ml, the maximum pen setting of 60 delivers 0.60 ml containing a calculated 100 mg of NAD+